NAVIDEA BIOPHARMACEUTICALS, INC.·4

Jul 5, 4:32 PM ET

Scott John K Jr. 4

4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jul 5, 2022

Insider Transaction Report

Form 4
Period: 2022-06-30
Transactions
  • Award

    Common Stock

    2022-06-30+2,5008,098,395 total
Holdings
  • Series G Redeemable Preferred Stock

    3,260
  • Common Stock

    (indirect: By Spouse)
    10,139
Footnotes (3)
  • [F1]Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
  • [F2]Issuance deferred at the request of the Reporting Person.
  • [F3]Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4